Purpose Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated
hospitalizations worldwide. This guidance paper describes the tailored treatment …

Objectives: The aim of this study was to review randomized controlled trials (RCTs) using
cardiac magnetic resonance (CMR) to assess myocardial infarct (MI) size in reperfused …

Aims To investigate in-hospital and long-term prognosis in T2DM patients presenting with
acute myocardial infarction (AMI) treated with SGLT2-I versus other oral anti-diabetic agents …

Background: Sodium glucose transporter-2 inhibitors reduce the risk of major adverse
cardiovascular events (MACE) in patients with type 2 diabetes mellitus and a history of …

Background: Ischemic heart disease is a leading cause of heart failure and despite
advanced therapeutic options, morbidity and mortality rates remain high. Although acute …

Background—The presence of intramyocardial hemorrhage (IMH) in ST-segment–elevation
myocardial infarction patients reperfused by primary percutaneous coronary intervention has …

Objectives: This study sought to establish the best definition of left ventricular adverse
remodeling (LVAR) to predict outcomes and determine whether its assessment adds …

Background Prediction of clinical outcome after acute myocardial infarction (AMI) is
challenging and would benefit from new biomarkers. We investigated the prognostic value of …

Background: Ischemic heart diseases are leading causes of death and reduced life quality
worldwide. Although revascularization strategies significantly reduce mortality after acute …

Taking its incidence and prognostic importance into account, acute ST-segment–elevation
myocardial infarction (STEMI) can be regarded as one of the most important challenges …